Abstract | OBJECTIVE: MATERIALS: This study compared the steady-state PK of GBP-IR 600 mg t.i.d., GBP-GR 1,800 mg q.d., and GEn 600 mg b.i.d. in healthy adults. METHODS: The open-label study consisted of a 3-day lead-in of escalating doses of GBP-IR, 5 days of treatment with each formulation (GPB-IR, GPB-GR, and GEn), and a 7-day taper period on 600 mg GEn q.d.. Plasma concentrations were collected on day 5 for each formulation. PK parameters were estimated from plasma concentration data. RESULTS: 14 healthy subjects (7 men, 7 women; mean (SD) age, 46.8 (7.60) years; mean (SD) body mass index, 26.7 (1.7) kg/m2) received all doses and completed the study. GBP-GR resulted in substantially (~ 4-fold) higher peak-to-trough ratio and percent fluctuation compared to GEn. GEn resulted in more sustained and less fluctuating daily exposure relative to GBP-IR, particularly at the end of 24 hours of dosing. In contrast, gabapentin fluctuation from GBP-IR consisted of 3 distinct peaks. After dose normalization, gabapentin exposure with GEn was ~ 2.2-fold and ~ 1.4-fold higher compared to GBP-GR and GBP-IR, respectively. All treatments were well tolerated. CONCLUSION: GEn requires less frequent dosing compared with GBP-IR and fluctuates less with sustained gabapentin exposure throughout the day. These PK differences may have clinically relevant implications.
.
|
Authors | Dennis Swearingen, Gerald M Aronoff, Sabrina Ciric, Ritu Lal |
Journal | International journal of clinical pharmacology and therapeutics
(Int J Clin Pharmacol Ther)
Vol. 56
Issue 5
Pg. 231-238
(May 2018)
ISSN: 0946-1965 [Print] Germany |
PMID | 29633699
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- Amines
- Analgesics
- Cyclohexanecarboxylic Acids
- Delayed-Action Preparations
- gamma-Aminobutyric Acid
- Gabapentin
|
Topics |
- Administration, Oral
- Adult
- Amines
(administration & dosage, blood, chemistry, pharmacokinetics)
- Analgesics
(administration & dosage, blood, chemistry, pharmacokinetics)
- Biological Availability
- Cyclohexanecarboxylic Acids
(administration & dosage, blood, chemistry, pharmacokinetics)
- Delayed-Action Preparations
- Drug Compounding
- Drug Monitoring
- Female
- Gabapentin
- Healthy Volunteers
- Humans
- Male
- Middle Aged
- Models, Biological
- Therapeutic Equivalency
- gamma-Aminobutyric Acid
(administration & dosage, blood, chemistry, pharmacokinetics)
|